Cargando…

Risk factor analysis of thymoma resection and its value in guiding clinical treatment

BACKGROUND: In this study, relationships between clinicopathologic characteristics and progression‐free survival (PFS) of patients after thymomectomy were analyzed to provide valuable suggestions regarding the treatment of thymoma. METHODS: Data from 187 thymoma patients undergoing surgery at Beijin...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xin, Cui, Jian, Yu, Xin‐tao, Yu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315718/
https://www.ncbi.nlm.nih.gov/pubmed/37156630
http://dx.doi.org/10.1002/cam4.6043
_version_ 1785067557120638976
author Du, Xin
Cui, Jian
Yu, Xin‐tao
Yu, Lei
author_facet Du, Xin
Cui, Jian
Yu, Xin‐tao
Yu, Lei
author_sort Du, Xin
collection PubMed
description BACKGROUND: In this study, relationships between clinicopathologic characteristics and progression‐free survival (PFS) of patients after thymomectomy were analyzed to provide valuable suggestions regarding the treatment of thymoma. METHODS: Data from 187 thymoma patients undergoing surgery at Beijing Tongren Hospital between January 1, 2006, and December 31, 2015, were retrospectively reviewed. We explored the risk factors for PFS among sex, age, thymoma‐associated MG, completeness of resection, histologic type and TNM stage, and investigated their interrelationship. RESULTS: Among the 187 patients, 18 patients (9.63%) had tumor recurrence/metastasis, and all of whom had in situ recurrence or pleural metastasis, and most of them (10 of 18 patients) had MG symptoms that reappeared or were aggravated. Fifteen patients (8.02%) died, and myasthenic crisis was a leading cause. Based on Cox regression analysis, only age (HR = 3.16; 95% CI: 1.44–6.91; p = 0.004) and the completeness of resection (HR = 9.03; 95% CI: 2.58–31.55; p = 0.001) were independent risk factors for PFS. Furthermore, we found that the completeness of resection was related to the histologic type (p = 0.009) and TNM stage (p < 0.001) by Fisher's exact test. CONCLUSIONS: The results of this cohort study remind us that we should pay attention to the reappearance or aggravation of MG after thymoma resection, because it is the leading cause of death and may indicate tumor progression. Furthermore, completeness of resection was related to the histologic type and TNM stage, but it was the independent risk factors of thymoma. Therefore, R0 resection is critical to the prognosis of thymoma.
format Online
Article
Text
id pubmed-10315718
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103157182023-07-04 Risk factor analysis of thymoma resection and its value in guiding clinical treatment Du, Xin Cui, Jian Yu, Xin‐tao Yu, Lei Cancer Med RESEARCH ARTICLES BACKGROUND: In this study, relationships between clinicopathologic characteristics and progression‐free survival (PFS) of patients after thymomectomy were analyzed to provide valuable suggestions regarding the treatment of thymoma. METHODS: Data from 187 thymoma patients undergoing surgery at Beijing Tongren Hospital between January 1, 2006, and December 31, 2015, were retrospectively reviewed. We explored the risk factors for PFS among sex, age, thymoma‐associated MG, completeness of resection, histologic type and TNM stage, and investigated their interrelationship. RESULTS: Among the 187 patients, 18 patients (9.63%) had tumor recurrence/metastasis, and all of whom had in situ recurrence or pleural metastasis, and most of them (10 of 18 patients) had MG symptoms that reappeared or were aggravated. Fifteen patients (8.02%) died, and myasthenic crisis was a leading cause. Based on Cox regression analysis, only age (HR = 3.16; 95% CI: 1.44–6.91; p = 0.004) and the completeness of resection (HR = 9.03; 95% CI: 2.58–31.55; p = 0.001) were independent risk factors for PFS. Furthermore, we found that the completeness of resection was related to the histologic type (p = 0.009) and TNM stage (p < 0.001) by Fisher's exact test. CONCLUSIONS: The results of this cohort study remind us that we should pay attention to the reappearance or aggravation of MG after thymoma resection, because it is the leading cause of death and may indicate tumor progression. Furthermore, completeness of resection was related to the histologic type and TNM stage, but it was the independent risk factors of thymoma. Therefore, R0 resection is critical to the prognosis of thymoma. John Wiley and Sons Inc. 2023-05-08 /pmc/articles/PMC10315718/ /pubmed/37156630 http://dx.doi.org/10.1002/cam4.6043 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Du, Xin
Cui, Jian
Yu, Xin‐tao
Yu, Lei
Risk factor analysis of thymoma resection and its value in guiding clinical treatment
title Risk factor analysis of thymoma resection and its value in guiding clinical treatment
title_full Risk factor analysis of thymoma resection and its value in guiding clinical treatment
title_fullStr Risk factor analysis of thymoma resection and its value in guiding clinical treatment
title_full_unstemmed Risk factor analysis of thymoma resection and its value in guiding clinical treatment
title_short Risk factor analysis of thymoma resection and its value in guiding clinical treatment
title_sort risk factor analysis of thymoma resection and its value in guiding clinical treatment
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315718/
https://www.ncbi.nlm.nih.gov/pubmed/37156630
http://dx.doi.org/10.1002/cam4.6043
work_keys_str_mv AT duxin riskfactoranalysisofthymomaresectionanditsvalueinguidingclinicaltreatment
AT cuijian riskfactoranalysisofthymomaresectionanditsvalueinguidingclinicaltreatment
AT yuxintao riskfactoranalysisofthymomaresectionanditsvalueinguidingclinicaltreatment
AT yulei riskfactoranalysisofthymomaresectionanditsvalueinguidingclinicaltreatment